Latest Breaking News On - Paul frohna - Page 1 : comparemela.com

ImCheck to Present Promising ICT01 Data from the EVICTION Study at ASCO 2024

ImCheck to Present Promising ICT01 Data from the EVICTION Study at ASCO 2024
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

France
Chicago
Illinois
United-states
Mccormick-place
American
Jorge-ram
Vladimir-galvao
Institut-paoli-calmettes
Katrien-lemmens
Gretchen-schweitzer
Maelle-mairesse

Dr Paul Frohna Discusses Promising Results of Novel Hedgehog Inhibitor for IPF

Promising results from a phase 2 trial of ENV-101, a novel hedgehog inhibitor, showed improvement in lung function and reduction of fibrosis in patients with idiopathic pulmonary fibrosis, said Paul Frohna, MD, PhD, PharmD.

California
United-states
San-diego
American
Paul-frohna
American-thoracic-society
International-conference
Endeavor-biomedicines
Novel-hedgehog-inhibitor
Increases-lung-function
Reduces-lung-fibrosis
Results-from

Endeavor BioMedicines' ENV-101 improves lung function and reverses fibrosis in IPF patients

Endeavor BioMedicines' ENV-101 improves lung function and reverses fibrosis in IPF patients
biopharma-reporter.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biopharma-reporter.com Daily Mail and Mail on Sunday newspapers.

United-states
American
Toby-maher
Paul-frohna
International-conference
Keck-school-of-medicine
American-thoracic-society
Keck-school
Endeavor-biomedicines

Endeavor BioMedicines Successfully Completes Phase 2a Trial of ENV-101 in Patients with Idiopathic Pulmonary Fibrosis

Endeavor BioMedicines Successfully Completes Phase 2a Trial of ENV-101 in Patients with Idiopathic Pulmonary Fibrosis
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Andrea-cohen
John-hood
Paul-frohna
Linkedin

ImCheck Presented Updated Positive Data from Phase I/IIa EVICTION-2 Trial of ICT01 in Combination with Low-dose IL-2 at SITC 2023

ImCheck Presented Updated Positive Data from Phase I/IIa EVICTION-2 Trial of ICT01 in Combination with Low-dose IL-2 at SITC 2023Interim data from.

San-diego
California
United-states
France
San-diego-convention-center
Volker-kunzmann
Institut-paoli-calmettes
Gretchen-schweitzer
Paul-frohna
Francois-xavier-danlos
Katrien-lemmens
Maelle-mairesse